logo

For the Inventor, By the Inventor

Escondido, CA, United States of America

Ronald R Tuttle

This inventor holds 22 USPTO granted patents, primarily in Cytokine Therapy. Top assignees: Trega Biosciences, Inc., Gensia Pharmaceuticals, Inc., Eli Lilly and Company. Active years: 1976-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald R Tuttle. Retrieved from https://idiyas.com/inventor/ronald-r-tuttle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 22

% Patents Active = 100.0

Average Co-Inventor Count = 2.9

ph-index = 13

Forward Citations = 592(Granted Patents)


Location History:

  • Indianapolis, IN (US) (1976)
  • Oceanside, CA (US) (1995)
  • Escondido, CA (US) (1989 - 2003)

Company Filing History:

goldMedal7 out of 22 
 
Trega Biosciences, Inc.
 patents
silverMedal5 out of 14 
 
Gensia Pharmaceuticals, Inc.
 patents
bronzeMedal3 out of 4,522 
 
Eli Lilly and Company
 patents
4. 2 out of 6 
 
Houghten Pharmaceuticals, Inc.
 patents
5. 2 out of 17 
 
Lion Bioscience Ag
 patents
6. 1 out of 1 
 
Baker Cumins Dermatologicals, Inc.
 patent
7. 1 out of 12 
 
Gensia, Inc.
 patents
8. 1 out of 5,649 
 
The University of Texas System
 patents

Years Active: 1976-2003

Loading Chart...
Areas of Expertise:
Cytokine Restraining Agents
Melanocortin Receptor-3
Sexual Dysfunction
Inflammatory Bowel Disease
Coronary Artery Disease
Cardiac Contractility
Aica Riboside Delivery
Rheumatoid Arthritis
Growth Promotion
CXC Intercrine Molecules
Pruritus Treatment
1,3-Benzodioxole
22 patents (USPTO):Explore Patents
1. 6534503 - Melanocortin receptor-3 ligands to treat sexual dysfunction (2003-03-18),
2. 6284735 - HP-3228 and related peptides to treat sexual dysfunction (2001-09-04),
3. 6245738 - Cytokine restraining agents (2001-06-12),
4. 5965536 - Methods of inhibiting CXC intercrine molecules (1999-10-12),
5. 5888978 - Method for reducing the severity of gastro-intestinal damage (1999-03-30),
6. 5888969 - Use of cytokine restraining agents to treat inflammatory bowel disease (1999-03-30),
7. 5786332 - Cytokine restraining agents and methods of use in pathologies and (1998-07-28),
8. 5760001 - Cytokine restraining agents and methods of use in pathologies and (1998-06-02),
9. 5741774 - Use of a cytokine regulatory agent to treat rheumatoid arthritis (1998-04-21),
10. 5726156 - Cytokine regulatory agents and methods of use in pathologies and (1998-03-10),
11. 5658889 - Method and compounds for aica riboside delivery and for lowering blood (1997-08-19),
12. 5643967 - Growth promotion (1997-07-01),
13. 5597843 - Use of a substituted 1,3-benzodioxole to reduce a wasting condition (1997-01-28),
14. 5460605 - Diagnosis, evaluation and treatment of coronary artery disease by (1995-10-24),
15. 5420109 - Cytokine restraining agents (1995-05-30),

Title: Inventor Ronald R Tuttle: Pioneering Innovations in Escondido

Introduction: Ronald R Tuttle is a distinguished inventor based in Escondido, California, known for his groundbreaking contributions to various fields.

Latest Patents: Ronald R Tuttle holds several patents in the areas of technology and engineering, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Ronald R Tuttle has established himself as a visionary inventor, with a keen focus on developing solutions that push the boundaries of traditional practices.

Collaborations: Throughout his career, Ronald R Tuttle has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of creativity and excellence.

Conclusion: Ronald R Tuttle's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in Escondido, California, inspiring future generations to think outside the box and pursue their inventive dreams.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…